Agex Therapeutics, Inc.
Annual report (10-K)
Latest 10-K/A filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Agex Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Moreadith Randall | Officer | 37 |
| Bailey Gregory | Director | 15 |
| Juvenescence Ltd | Director10% Owner | 8 |
| Ledger Steven A | OfficerDirector | 5 |
| Mintz Steven | Director | 5 |
Showing 1-5 of 16
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Agex Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Moreadith Randall | 31 | 94% | +32.6% | +37.1% | +59.8% | -25.0% |
| 2 | Mintz Steven | 14 | 7% | -20.6% | -22.3% | +2.6% | -27.7% |
| 3 | Bailey Gregory | 16 | 6% | -19.6% | -18.1% | +2.9% | -39.4% |
All filings
95 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|